Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis

Authors: Luis Anibarro, Matilde Trigo, Diana Feijoó, Mónica Ríos, Luisa Palomares, Alberto Pena, Marta Núñez, Carlos Villaverde, África González-Fernández

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Patients with end-stage renal disease (ESRD) and Mycobacterium tuberculosis infection pose a high risk of developing active TB disease. It is therefore important to detect latent TB infection (LTBI) to be able to offer treatment and prevent progression to TB disease. We assessed the value of the tuberculin skin test (TST) and of an interferon-gamma release assay (Quantiferon®-TB Gold in-Tube, QFT) for diagnosing LTBI in ESRD patients, after prolonged exposure to a highly contagious TB case in a haemodialysis unit. As a high number of patients presented erythema without induration in the TST response, this type of reaction was also analysed.

Method

The TST and QFT were simultaneously performed twelve weeks after the last possible exposure to a bacilliferous TB patient. If the first TST (TST-1) was negative, a second TST (TST-2) was performed 15 days later to detect a booster response. A comparison was made between the TST responses (including those cases with erythema without induration) and those for the QFT. The correlation with risk of infection and the concordance between tests were both analysed.

Results

A total of 52 patients fulfilled the inclusion criteria. Overall, 11 patients (21.2%) had a positive TST response: 3 for TST-1 and 8 for TST-2, and 18 patients (34.6%) showed a positive QFT response (p = 0.065). Erythema without induration was found in 3 patients at TST-1 and in a further 9 patients at TST-2. The three patients with erythema without induration in TST-1 had a positive TST-2 response. Concordance between TST and QFT was weak for TST-1 (κ = 0.21); it was moderate for overall TST (κ = 0.49); and it was strong if both induration and erythema (κ = 0.67) were considered.

Conclusions

In patients with ESRD, erythema without induration in the TST response could potentially be an indicator of M. tuberculosis infection. The QFT shows better accuracy for LTBI diagnosis than the TST.
Appendix
Available only for authorised users
Literature
1.
go back to reference García-Leoni ME, Martín-Scapa C, Rodeño P, Valderrábano F, Moreno S, Bouza E: High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis. 1990, 9: 283-285. 10.1007/BF01968062.CrossRefPubMed García-Leoni ME, Martín-Scapa C, Rodeño P, Valderrábano F, Moreno S, Bouza E: High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis. 1990, 9: 283-285. 10.1007/BF01968062.CrossRefPubMed
2.
go back to reference Sasaki S, Akiba T, Suenaga M, Tomura S, Yoshiyama N, Nakagawa S, Shoji T, Sasaoka T, Takeuchi J: Ten years’ survey of dialysis-associated tuberculosis. Nephron. 1979, 24: 141-145. 10.1159/000181703.CrossRefPubMed Sasaki S, Akiba T, Suenaga M, Tomura S, Yoshiyama N, Nakagawa S, Shoji T, Sasaoka T, Takeuchi J: Ten years’ survey of dialysis-associated tuberculosis. Nephron. 1979, 24: 141-145. 10.1159/000181703.CrossRefPubMed
3.
go back to reference Segall L, Covic A: Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol. 2010, 5: 1114-1122. 10.2215/CJN.09231209.CrossRefPubMed Segall L, Covic A: Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol. 2010, 5: 1114-1122. 10.2215/CJN.09231209.CrossRefPubMed
4.
go back to reference National Tuberculosis Controllers Association, Centers for Disease Control and Prevention: Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005, 54: 1-47. National Tuberculosis Controllers Association, Centers for Disease Control and Prevention: Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005, 54: 1-47.
5.
go back to reference Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, Valway SE, Onorato IM, Group CIS: Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA. 2002, 287: 991-995. 10.1001/jama.287.8.991.CrossRefPubMed Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, Valway SE, Onorato IM, Group CIS: Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA. 2002, 287: 991-995. 10.1001/jama.287.8.991.CrossRefPubMed
6.
go back to reference (CDC) CfDCaP: Tuberculosis transmission in a renal dialysis center--Nevada, 2003. MMWR Morb Mortal Wkly Rep. 2004, 53: 873-875. (CDC) CfDCaP: Tuberculosis transmission in a renal dialysis center--Nevada, 2003. MMWR Morb Mortal Wkly Rep. 2004, 53: 873-875.
7.
go back to reference Santin M, Dominguez J: Diagnosis of tuberculosis infection using interferon-gamma based assays. Enferm Infecc Microbiol Clin. 2011, 29: 26-33.CrossRef Santin M, Dominguez J: Diagnosis of tuberculosis infection using interferon-gamma based assays. Enferm Infecc Microbiol Clin. 2011, 29: 26-33.CrossRef
8.
go back to reference Shankar MS, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL, Sakhuja V, Jha V: The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant. 2005, 20: 2720-2724. 10.1093/ndt/gfi141.CrossRefPubMed Shankar MS, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL, Sakhuja V, Jha V: The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant. 2005, 20: 2720-2724. 10.1093/ndt/gfi141.CrossRefPubMed
9.
go back to reference Wauters A, Peetermans WE, Van den Brande P, De Moor B, Evenepoel P, Keuleers H, Kuypers D, Stas K, Vanwalleghem J, Vanrenterghem Y, Maes BD: The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant. 2004, 19: 433-438. 10.1093/ndt/gfg569.CrossRefPubMed Wauters A, Peetermans WE, Van den Brande P, De Moor B, Evenepoel P, Keuleers H, Kuypers D, Stas K, Vanwalleghem J, Vanrenterghem Y, Maes BD: The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant. 2004, 19: 433-438. 10.1093/ndt/gfg569.CrossRefPubMed
10.
go back to reference Woeltje KF, Mathew A, Rothstein M, Seiler S, Fraser VJ: Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis. 1998, 31: 848-852. 10.1016/S0272-6386(98)70055-1.CrossRefPubMed Woeltje KF, Mathew A, Rothstein M, Seiler S, Fraser VJ: Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis. 1998, 31: 848-852. 10.1016/S0272-6386(98)70055-1.CrossRefPubMed
11.
go back to reference Smirnoff M, Patt C, Seckler B, Adler JJ: Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest. 1998, 113: 25-27. 10.1378/chest.113.1.25.CrossRefPubMed Smirnoff M, Patt C, Seckler B, Adler JJ: Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest. 1998, 113: 25-27. 10.1378/chest.113.1.25.CrossRefPubMed
12.
go back to reference Sester M, Sester U, Clauer P, Heine G, Mack U, Moll T, Sybrecht GW, Lalvani A, Köhler H: Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int. 2004, 65: 1826-1834. 10.1111/j.1523-1755.2004.00586.x.CrossRefPubMed Sester M, Sester U, Clauer P, Heine G, Mack U, Moll T, Sybrecht GW, Lalvani A, Köhler H: Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int. 2004, 65: 1826-1834. 10.1111/j.1523-1755.2004.00586.x.CrossRefPubMed
13.
go back to reference Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, et al: Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011, 37: 88-99. 10.1183/09031936.00115110.CrossRefPubMed Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, et al: Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011, 37: 88-99. 10.1183/09031936.00115110.CrossRefPubMed
14.
go back to reference Milburn H, Ashman N, Davies P, Doffman S, Drobniewski F, Khoo S, Ormerod P, Ostermann M, Snelson C, Committee BTSSoCCaJT: Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax. 2010, 65: 557-570.CrossRefPubMed Milburn H, Ashman N, Davies P, Doffman S, Drobniewski F, Khoo S, Ormerod P, Ostermann M, Snelson C, Committee BTSSoCCaJT: Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax. 2010, 65: 557-570.CrossRefPubMed
15.
go back to reference Arend S, Thijsen S, Leyten E, Bouwman J, Franken W, Koster B, Cobelens F, van Houte A, Bossink A: Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007, 175: 618-627. 10.1164/rccm.200608-1099OC.CrossRefPubMed Arend S, Thijsen S, Leyten E, Bouwman J, Franken W, Koster B, Cobelens F, van Houte A, Bossink A: Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007, 175: 618-627. 10.1164/rccm.200608-1099OC.CrossRefPubMed
16.
go back to reference Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, Swarbrick G, Johnson C, Lewinsohn DA, Lewinsohn DM, Mazurek GH: Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol. 2008, 3: 1357-1363. 10.2215/CJN.01010208.CrossRefPubMedPubMedCentral Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, Swarbrick G, Johnson C, Lewinsohn DA, Lewinsohn DM, Mazurek GH: Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol. 2008, 3: 1357-1363. 10.2215/CJN.01010208.CrossRefPubMedPubMedCentral
17.
go back to reference Connell DW, Singanayagam A, Charif R, George PM, Molyneaux PL, McCrudden C, Magtoto M, Harden E, Seneviratne SL, Duncan ND, Kon OM: A comparison between interferon gamma release assays and the tuberculin skin test in the contact tracing of patients with chronic kidney disease. Thorax. 2011, 66: 729-730. 10.1136/thx.2010.149088.CrossRefPubMed Connell DW, Singanayagam A, Charif R, George PM, Molyneaux PL, McCrudden C, Magtoto M, Harden E, Seneviratne SL, Duncan ND, Kon OM: A comparison between interferon gamma release assays and the tuberculin skin test in the contact tracing of patients with chronic kidney disease. Thorax. 2011, 66: 729-730. 10.1136/thx.2010.149088.CrossRefPubMed
18.
go back to reference González-Martín J, García-García J, Anibarro L, Vidal R, Esteban J, Blanquer R, Moreno S, Ruiz-Manzano J: [Consensus document on the diagnosis, treatment and prevention of tuberculosis]. Enferm Infecc Microbiol Clin. 2010, 28: 297-e291-e220CrossRefPubMed González-Martín J, García-García J, Anibarro L, Vidal R, Esteban J, Blanquer R, Moreno S, Ruiz-Manzano J: [Consensus document on the diagnosis, treatment and prevention of tuberculosis]. Enferm Infecc Microbiol Clin. 2010, 28: 297-e291-e220CrossRefPubMed
19.
go back to reference Touraine JL, Touraine F, Revillard JP, Brochier J, Traeger J: T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. Nephron. 1975, 14: 195-208. 10.1159/000180448.CrossRefPubMed Touraine JL, Touraine F, Revillard JP, Brochier J, Traeger J: T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. Nephron. 1975, 14: 195-208. 10.1159/000180448.CrossRefPubMed
20.
go back to reference Alvarez-Lara MA, Carracedo J, Ramírez R, Martín-Malo A, Rodríguez M, Madueño JA, Aljama P: The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset. Nephrol Dial Transplant. 2004, 19: 3084-3090. 10.1093/ndt/gfh382.CrossRefPubMed Alvarez-Lara MA, Carracedo J, Ramírez R, Martín-Malo A, Rodríguez M, Madueño JA, Aljama P: The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset. Nephrol Dial Transplant. 2004, 19: 3084-3090. 10.1093/ndt/gfh382.CrossRefPubMed
21.
go back to reference Dogan E, Erkoc R, Sayarlioglu H, Uzun K: Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients. Ren Fail. 2005, 27: 425-428.CrossRefPubMed Dogan E, Erkoc R, Sayarlioglu H, Uzun K: Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients. Ren Fail. 2005, 27: 425-428.CrossRefPubMed
22.
go back to reference Cengiz K, Seker A: Boosted tuberculin skin testing in hemodialysis patients. Am J Infect Control. 2006, 34: 383-387. 10.1016/j.ajic.2005.12.003.CrossRefPubMed Cengiz K, Seker A: Boosted tuberculin skin testing in hemodialysis patients. Am J Infect Control. 2006, 34: 383-387. 10.1016/j.ajic.2005.12.003.CrossRefPubMed
23.
go back to reference Menzies D: Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999, 159: 15-21.CrossRefPubMed Menzies D: Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999, 159: 15-21.CrossRefPubMed
24.
go back to reference Akcay A, Erdem Y, Altun B, Usalan C, Agca E, Yasavul U, Turgan C, Caglar S: The booster phenomenon in 2-step tuberculin skin testing of patients receiving long-term hemodialysis. Am J Infect Control. 2003, 31: 371-374. 10.1016/S0196-6553(02)48238-7.CrossRefPubMed Akcay A, Erdem Y, Altun B, Usalan C, Agca E, Yasavul U, Turgan C, Caglar S: The booster phenomenon in 2-step tuberculin skin testing of patients receiving long-term hemodialysis. Am J Infect Control. 2003, 31: 371-374. 10.1016/S0196-6553(02)48238-7.CrossRefPubMed
25.
go back to reference Habesoğlu MA, Torun D, Demiroglu YZ, Karatasli M, Sen N, Ermis H, Ozdemir N, Eyuboglu FO: Value of the tuberculin skin test in screening for tuberculosis in dialysis patients. Transplant Proc. 2007, 39: 883-886. 10.1016/j.transproceed.2007.02.035.CrossRefPubMed Habesoğlu MA, Torun D, Demiroglu YZ, Karatasli M, Sen N, Ermis H, Ozdemir N, Eyuboglu FO: Value of the tuberculin skin test in screening for tuberculosis in dialysis patients. Transplant Proc. 2007, 39: 883-886. 10.1016/j.transproceed.2007.02.035.CrossRefPubMed
26.
go back to reference Soysal A, Toprak D, Koc M, Arikan H, Akoglu E, Bakir M: Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?. Nephrol Dial Transplant. 2012, 27: 1645-1650. 10.1093/ndt/gfr516.CrossRefPubMed Soysal A, Toprak D, Koc M, Arikan H, Akoglu E, Bakir M: Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?. Nephrol Dial Transplant. 2012, 27: 1645-1650. 10.1093/ndt/gfr516.CrossRefPubMed
27.
go back to reference Anibarro L, Trigo M, Villaverde C, Pena A, González-Fernández A: Tuberculin skin test and interferon-γ release assay show better correlation after the tuberculin ‘window period’ in tuberculosis contacts. Scand J Infect Dis. 2011, 43: 424-429. 10.3109/00365548.2011.558912.CrossRefPubMed Anibarro L, Trigo M, Villaverde C, Pena A, González-Fernández A: Tuberculin skin test and interferon-γ release assay show better correlation after the tuberculin ‘window period’ in tuberculosis contacts. Scand J Infect Dis. 2011, 43: 424-429. 10.3109/00365548.2011.558912.CrossRefPubMed
28.
go back to reference Koike R, Takeuchi T, Eguchi K, Miyasaka N, Rheumatology JCo: Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol. 2007, 17: 451-458. 10.1007/s10165-007-0626-3.CrossRefPubMed Koike R, Takeuchi T, Eguchi K, Miyasaka N, Rheumatology JCo: Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol. 2007, 17: 451-458. 10.1007/s10165-007-0626-3.CrossRefPubMed
29.
go back to reference Toivgoogiin A, Toyota M, Yasuda N, Ohara H: Validity of using tuberculin skin test erythema measurement for contact investigation during a tuberculosis outbreak in schoolchildren previously vaccinated with BCG. J Epidemiol. 2005, 15: 56-64. 10.2188/jea.15.56.CrossRefPubMed Toivgoogiin A, Toyota M, Yasuda N, Ohara H: Validity of using tuberculin skin test erythema measurement for contact investigation during a tuberculosis outbreak in schoolchildren previously vaccinated with BCG. J Epidemiol. 2005, 15: 56-64. 10.2188/jea.15.56.CrossRefPubMed
30.
go back to reference Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, Tsai HC, Wann SR, Lin HH, Liu YC: High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection. 2009, 37: 96-102. 10.1007/s15010-008-8082-3.CrossRefPubMed Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, Tsai HC, Wann SR, Lin HH, Liu YC: High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection. 2009, 37: 96-102. 10.1007/s15010-008-8082-3.CrossRefPubMed
31.
go back to reference Seyhan EC, Sökücü S, Altin S, Günlüoğlu G, Trablus S, Yilmaz D, Koksalan OK, Issever H: Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis. 2010, 12: 98-105. 10.1111/j.1399-3062.2009.00469.x.CrossRefPubMed Seyhan EC, Sökücü S, Altin S, Günlüoğlu G, Trablus S, Yilmaz D, Koksalan OK, Issever H: Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis. 2010, 12: 98-105. 10.1111/j.1399-3062.2009.00469.x.CrossRefPubMed
32.
go back to reference Chung WK, Zheng ZL, Sung JY, Kim S, Lee HH, Choi SJ, Yang J: Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microbiol Infect. 2010, 16: 960-965.CrossRefPubMed Chung WK, Zheng ZL, Sung JY, Kim S, Lee HH, Choi SJ, Yang J: Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microbiol Infect. 2010, 16: 960-965.CrossRefPubMed
33.
go back to reference Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, Saudan P, Janssens JP: Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant. 2009, 24: 1952-1956. 10.1093/ndt/gfn748.CrossRefPubMed Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, Saudan P, Janssens JP: Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant. 2009, 24: 1952-1956. 10.1093/ndt/gfn748.CrossRefPubMed
34.
go back to reference Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M: Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol. 2007, 2: 68-73.CrossRefPubMed Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M: Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol. 2007, 2: 68-73.CrossRefPubMed
35.
go back to reference Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A: Negative and Positive Predictive Value of a Whole-Blood Interferon-{gamma} Release Assay for Developing Active Tuberculosis: An Update. Am J Respir Crit Care Med. 2011, 183: 88-95. 10.1164/rccm.201006-0974OC.CrossRefPubMed Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A: Negative and Positive Predictive Value of a Whole-Blood Interferon-{gamma} Release Assay for Developing Active Tuberculosis: An Update. Am J Respir Crit Care Med. 2011, 183: 88-95. 10.1164/rccm.201006-0974OC.CrossRefPubMed
36.
go back to reference Piana F, Codecasa LR, Cavallerio P, Ferrarese M, Migliori GB, Barbarano L, Morra E, Cirillo DM: Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J. 2006, 28: 31-34. 10.1183/09031936.06.00110205.CrossRefPubMed Piana F, Codecasa LR, Cavallerio P, Ferrarese M, Migliori GB, Barbarano L, Morra E, Cirillo DM: Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J. 2006, 28: 31-34. 10.1183/09031936.06.00110205.CrossRefPubMed
Metadata
Title
Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis
Authors
Luis Anibarro
Matilde Trigo
Diana Feijoó
Mónica Ríos
Luisa Palomares
Alberto Pena
Marta Núñez
Carlos Villaverde
África González-Fernández
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-195

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.